Targeted in vivo agents on the ASK
Products (List of agents)
2-DG probe
NIR targeted probe for non-invasive imaging of glucose uptake of tumors in vivo.
Annexin-Vivo™
In vivo targeting of membrane-bound phosphatidylserine exposed during the early stages of apoptosis.
BacteriSense™
Fast-clearing, targeted probe which binds to negatively charged lipids on the bacterial cell membrane, enabling the monitoring of infection progression in real time.
Bacterial Detection Probe
NIR targeted probe for non-invasive detection of bacterial infections in vivo.
BombesinRSense
NIR targeted probe specific to bombesin receptors, which are expressed in many types of cancers.
COX-2 probe
Imaging probe that specifically detects cyclooxygenase-2 (COX-2), produced in early-stage cancer cells.
FolateRSense™
Highly specific and sensitive in detection of Folate Receptor protein. Can be used to closely monitor and quantitate tumor growth and metabolism.
GFR-Vivo Agent
Near infrared (NIR) fluorescent-labeled form of inulin. Enables assessment of Glomerular filtration rate (GFR) by measurement of the rate of disappearance of labeled inulin from the blood.
HypoxiSense™
Fluorescent imaging agent that detects the tumor cell surface expression of carbonic anhydrase 9 (CA IX) protein, which increases in hypoxic regions within many tumors, especially in cervical, colorectal, non-small cell lung tumors.
IntegriSense™
Potent antagonist targeting integrin αγβ3, expressed in oncology, atherosclerosis and angiogensis disease models. Small molecule fluorochrome to label target ligand.
OsteoSense™
Fluorescent in vivo bisphosphonate imaging agent that targets areas of micro-calcifications and bone remodeling and enables imaging of bone growth and resorption.
TLectinSense™
Near-infrared dye-labeled macromolecule that targets the vasculature and enables imaging of blood vessels and angiogenesis.
Transferrin-Vivo
Near infrared (NIR) targeted fluorescent imaging agent consisting of recombinant transferrin conjugated to VivoTag dye, designed to bind to transferrin receptors expressed in cancer cells.
- Application Support Knowledge Base Home
- In Vivo and Preclinical Imaging
- Acute inflammation preclinical and in vivo imaging
- Angiogenesis on the ASK
- Arthritis on the ASK
- Atherosclerosis on the ASK
- Bacterial Infection on the ASK
- Bone biology and preclinical imaging
- Oncology on the ASK
- Pulmonary inflammation and preclinical imaging
- Vascular disease on the ASK
- Bioluminescent Cell Lines
- Light-producing microbes on the ASK
- RediFect lentiviral particles for in vivo and ex vivo imaging
- Luciferin and Coelenterazine Substrates
- Activatable imaging agents on the ASK
- Targeted in vivo agents on the ASK
- Vascular in vivo agents on the ASK
- AngioSense on the ASK
- AngioSPARK on the ASK
- Annexin Vivo on ASK
- Bacterial Detection Probe on the ASK
- BacteriSense on the ASK
- BombesinRSense on the ASK
- CAT B FAST on the ASK
- CAT K FAST on the ASK
- COX-2 probe on the ASK
- FolateRSense on the ASK
- GastroSense on the ASK
- Genhance on the ASK
- GFR-Vivo on the ASK
- HypoxiSense on the ASK
- IntegriSense on the ASK
- MMPSense on the ASK
- Neutrophil Elastase on the ASK
- OsteoSense on the ASK
- ProSense on the ASK
- PSA FAST on the ASK
- Rediject 2-DG on the ASK
- ReninSense on the ASK
- Superhance on the ASK
- TLectinSense on the ASK
- Transferrin-Vivo 750 on the ASK
- VivoTag on the ASK
- Depilation on the ASK
- IP injections for NIRF agents on ASK
- Lateral tail vein injections on the ASK
- Radioimaging on the ASK